Fortress Biotech Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Good afternoon, everyone. Welcome to our first afternoon here at Oppenheimer's Virtual Fall Healthcare Life Sciences and MedTech Summit. We are very happy to have with us for this session Fortress Biotech.
Fortress is developing a variety of candidates in different therapeutic areas and different stages of clinical trials and also maintains stakes in other innovative companies. We have Lindsay Rosenwald, who is the Company's Chairman and CEO, as well as Bill Begien on the IR team. (Operator Instructions). With that, I'll turn the podium over to Lindsay.
Thanks, Leland. Thanks so much to the Oppenheimer team for the opportunity to present today. And obviously also thanks to everybody who is watching this presentation. First, I will be making some forward-looking statements. Feel free to look at our SEC filings for all our risk factors and complete financials.
This is a snapshot of what we have going on at Fortress
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |